AMENDMENT NO. 1 TO SALES AGREEMENTSales Agreement • December 4th, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 4th, 2020 Company Industry JurisdictionThis AMENDMENT NO. 1 TO SALES AGREEMENT (this “Amendment”) dated as of December 4, 2020, by and between Sorrento Therapeutics, Inc. (the “Company”) and A.G.P./Alliance Global Partners (the “Agent”). Each of the Company and the Agent shall be referred to collectively as the “Parties” and individually as a “Party.”